Filing Flows › Cerus (CERS) › Recalls, complaints & regulation
Cerus (CERS): clinical trials
Cerus (CERS) beyond its filings: 5 active clinical trials.
Cerus' latest quarter
Cerus, Q3 2026: revenue $57.7M (+10% year over year), operating margin 0.7%, net loss $580K, operating cash flow $3.0M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Cerus have?
5 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.